Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Lung Cancer Video Library - Spanish Language: Video #43 The Treatment of Early Stage Non-Small Cell Lung Cancer
Anonymous
We are pleased to continue this series of informational videos for our Spanish speaking community. GRACE is pleased to welcome Dr. Rafael Santana-Davila, Assistant Professor with the University of Washington School of Medicine and Seattle Cancer Care Alliance. In this 43rd video for the Spanish lung cancer video library, Dr. Santana-Davila joined GRACE to discuss the treatment of early stage non-small cell lung cancer.
Tratamiento de Cancer de Células no Pequeñas Cuando Están en un Estadio Temprano
Treatment of Early Stage Non-small Cell Lung Cancer
Assistant Professor of Medicine
University of Washington Seattle Cancer Care Alliance
Seattle, Washington
Spanish TRANSCRIPT
El cancer de pulmón cuando se encuentra en estadio I o II, el mejor tratamiento es cirugía tratando de quitar el cancer. En la mayoría de las veces, lo que se hace es llevar el paciente a cirugía, quitar el cancer de donde está quitando todo el lóbulo del pulmón y muchos de los ganglios de alrededor. Si los ganglios no están involucrados, el tratamiento es quirúrgico sin ninguno otro tratamiento adicional. Si los ganglios están involucrados, se dará también quimioterapia adyuvante después de la cirugía para erradicar pequeñas células que estén en otros lados del cuerpo. El objetivo del tratamiento es tratar de curar al paciente.
El problema de muchos pacientes es que la cirugía puede ser muy peligrosa porque el pulmón de estos pacientes no es sano y quitar un lóbulo de un pulmón pude ser muy dañino. En estos casos, también se puede tratar con una radiación local.
English TRANSCRIPT
When the lung cancer is in stage one or two, the best treatment is surgery to try to remove the cancer. In most cases, the patient goes into surgery where they eliminate the cancer by removing the lobe of the lung and some of the lymph nodes nearby. If the lymph nodes are not involved, the treatment is only surgical. However, if the lymph nodes are involved, after the surgery the patient has to take adjuvant chemotherapy to eradicate small cells that are in other parts of the body. The main goal is to try to cure the patient.
The problem in some patients is that surgery can be very dangerous because the lung in these patients is not a healthy lung, so by removing its lobe can be quite harmful. In these cases, the treatment can be just local radiation.
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Video
This live virtual event, led by Dr. Andrew Srisuwananukorn on October 25, 2025, brought together top oncologists to share the latest updates in blood cancer treatment. The program featured patient-focused presentations, expert panel discussions, and a real-time Q&A session where attendees could engage directly with specialists.
To watch the complete playlist, click here.
Image
Video
In this video series led by Dr. Siddharth Sheth and recorded on October 27, 2025, a panel of leading oncologists engages in a dynamic and insightful roundtable discussion as they share newly released data, key highlights, and significant developments in head and neck cancer treatment while addressing the most pressing questions, delivered in a concise and easy-to-understand format.
To watch the complete playlist, click here.
Image
Video
In this series, Vernon Sondak, Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, and Fiorinda Muhaj, MD Anderson Cancer Center, discuss basal and squamous cell carcinoma, including diagnosis, treatment options, and skin cancer prevention.
To watch the complete playlist, click here.
Thanks to Regeneron and Daiichi-Sankyo.
Online Community
Dr. Singhi's reprise about appropriate treatment, "Right patient, right time, right team".
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.